Infection with the human T-cell leukemia virus-1 (HTLV-1) results in a variety of diseases including adult T-cell leukemia/ lymphoma (ATL).
IntroductionHuman T-cell Leukemia Virus-1 (HTLV-1) is a CD4 ϩ T cell-tropic human deltaretrovirus infecting 10-20 million people worldwide. 1,2 HTLV-1 was the first human retrovirus isolated and is the causative agent of diverse diseases such as Adult T-cell Leukemia/ Lymphoma (ATL), a fatal CD4 ϩ T-cell Leukemia/Lymphoma and HTLV-1 Acquired Myelopathy/Tropical Spastic Paraparesis (HAM-TSP), a demyelinating disease of the spinal cord. Approximately 3%-5% of those infected with HTLV-1 will develop disease, while the majority of carriers remain asymptomatic. Development of HAM/TSP or ATL occurs after long clinically latent periods and specific disease phenotypes tend to be associated with particular routes and timing of infection. 3 The mechanisms responsible for HTLV-1 pathogenesis remain poorly understood.Development of HTLV-1-associated diseases is dependent upon expression of HTLV-1 gene products, most notably the HTLV-1 viral transcriptional transactivator, Tax 4 and other regulatory proteins including the HBZ protein. 5,6 Tax expression is required for viral replication, and can induce CD4 ϩ T-cell immortalization. Tax enhances viral gene expression through interactions with cellular transcription factors at the HTLV-1 Long Terminal Repeat (LTR) promoter. Tax also interacts with many host proteins involved in cell survival, proliferation, genomic stability, and cell cycle regulation to promote altered cellular gene expression. 4 Thus, Tax plays a critical role in regulating viral gene expression, as well as the host cellular response to infection. Recently, HBZ has also been shown to play an important role in HTLV-1 pathogenesis both through increased viral load, and enhancing T-cell proliferation in culture and transgenic mice. 7,8 p12 I , an activator of STAT5 antiapoptotic signaling is also likely to play a role in HTLV-1 transformation. 9 Determining the cellular and viral events that regulate HTLV-1 gene expression is central to understanding pathogenesis of HTLV-1 infection. Our laboratory has previously shown that Tax expression in chronically infected human CD4 ϩ T cells can be markedly enhanced by immune activation stimuli, such as PMA, PHA, or anti-CD3 antibody. 10,11 These data suggest that immune stimulation of infected cells, through T-cell antigen receptor signaling, could regulate a balance of virus-host interactions leading to increased viral gene expression.To elucidate whether immune activation events contribute to HTLV-1-associated-diseases, study of animal models of pathogenesis will be valuable. Although mouse models of Tax-associated oncogenesis have been described, 12-14 a transgenic model of Tax-derived CD4 ϩ T-cell oncogenesis, reflecting regulation of Tax by the authentic HTLV-1 LTR has yet to be established. Transgenic mice expressing Tax under the control of the LTR, are phenotypically normal until approximately 3 months of age, when they deve...